PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 93 filers reported holding PMV PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $403,146 | -42.2% | 84,517 | +5.5% | 0.00% | -50.0% |
| Q4 2022 | $697,122 | -67.1% | 80,129 | -55.0% | 0.00% | -66.7% |
| Q3 2022 | $2,119,000 | +217.7% | 178,078 | +280.3% | 0.01% | +200.0% |
| Q2 2022 | $667,000 | -56.7% | 46,824 | -29.8% | 0.00% | -73.3% |
| Q4 2021 | $1,542,000 | +30.1% | 66,743 | +67.9% | 0.02% | 0.0% |
| Q3 2021 | $1,185,000 | +199.2% | 39,751 | +242.7% | 0.02% | +275.0% |
| Q2 2021 | $396,000 | – | 11,599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |